Skip to main content
. Author manuscript; available in PMC: 2018 Apr 15.
Published in final edited form as: Clin Infect Dis. 2017 Apr 15;64(8):1115–1122. doi: 10.1093/cid/cix091

Table 2.

Meningococcal Carriage and Serogroups

Meningococcal Carriage Round 1: February 2015, N (%) Round 2: April 2015, N (%) Round 3: September 2015, N (%) Round 4: March 2016, N (%)
Total participants 717 878 622 626
Neisseria meningitidis carriage 175 (24) 211 (24) 123 (20) 130 (21)
Meningococcal serogroup
By real-time polymerase chain reactiona
 A 0 (0) 0 (0) 0 (0) 0 (0)
 B 31 (4) 36 (4) 26 (4) 22 (4)
 C 8 (1) 3 (0.3) 0 (0) 0 (0)
 W 0 (0) 0 (0) 1 (0.2) 1 (0.2)
 X 1 (0.1) 2 (0.2) 0 (0) 5 (1)
 Y 3 (0.4) 4 (0.5) 1 (0.2) 2 (0.3)
 Nongroupable 132 (18) 166 (19) 95 (15) 100 (16)
By slide agglutinationb
 A 0 (0) 0 (0) 0 (0) 0 (0)
 B 9 (1) 12 (1) 7 (1) 6 (1)
 C 1 (0.1) 0 (0) 0 (0) 0 (0)
 Ec 4 (1) 4 (0.5) 6 (1) 8 (1)
 W 0 (0) 0 (0) 0 (0) 0 (0)
 X 3 (0.4) 2 (0.2) 0 (0) 0 (0)
 Y 2 (0.3) 2 (0.2) 0 (0) 0 (0)
 Zc 0 (0) 0 (0) 1 (0.2) 0 (0)
 Nongroupable 156 (22) 191 (22) 109 (18) 116 (19)
a

In round 1, 18% of 175 isolates were serogroup B, 5% were serogroup C, 1% were serogroup X, 2% were serogroup Y, and 75% were nongroupable by real-time polymerase chain reaction. Similarly, round 2 isolates were 17% B, 1% C, 1% X, 2% Y, and 79% nongroupable; round 3 isolates were 21% B, 1% W, 1% Y, and 77% nongroupable; and round 4 isolates were 17% B, 1% W, 4% X, 2% Y, and 77% nongroupable.

b

In round 1, 5% of 175 isolates were serogroup B, 1% were serogroup C, 2% were serogroup E, 2% were serogroup X, 1% were serogroup Y, and 89% were nongroupable by slide agglutination. Similarly, round 2 isolates were 6% B, 2% E, 1% X, 1% Y, and 91% nongroupable; round 3 isolates were 6% B, 5% E, 1% Z, and 89% nongroupable; and round 4 isolates were 5% B, 6% E, and 89% nongroupable.

c

Serogroups E and Z were only assessed via slide agglutination, not by real-time polymerase chain reaction.